MetLife Total Current Assets vs Non Current Liabilities Total Analysis

MET Stock

USD 85.51 1.48 1.76%

MetLife financial indicator trend analysis is infinitely more than just investigating MetLife recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MetLife is a good investment. Please check the relationship between MetLife Total Current Assets and its Non Current Liabilities Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.

Total Current Assets vs Non Current Liabilities Total

Total Current Assets vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MetLife Total Current Assets account and Non Current Liabilities Total. At this time, the significance of the direction appears to have no relationship.

The correlation between MetLife's Total Current Assets and Non Current Liabilities Total is 0.05. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of MetLife, assuming nothing else is changed. The correlation between historical values of MetLife's Total Current Assets and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of MetLife are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Total Current Assets i.e., MetLife's Total Current Assets and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

0.05

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Non Current Liabilities Total

Most indicators from MetLife's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MetLife current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.At this time, MetLife's Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 21.48 in 2024, whereas Selling General Administrative is likely to drop slightly above 5.8 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	71.1B	69.9B	66.4B	52.8B
Total Revenue	71.1B	69.9B	66.4B	52.8B

Gross Profit Total Revenue

MetLife fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Other Liab	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Inventory
Common Stock Shares Outstanding		0.76	0.62	0.85	0.85	0.75	0.69	-0.12	-0.25	-0.22	0.39	-0.5	0.92	0.75	0.08	-0.47	-0.23	-0.42	0.58	0.51	-0.16	0.42	0.56	0.09	0.41	0.66
Total Assets	0.76		0.77	0.5	0.49	0.82	0.4	0.51	0.35	-0.13	0.7	-0.2	0.85	1.0	0.24	-0.85	0.15	-0.3	0.47	0.27	0.1	0.73	0.89	0.62	0.7	0.17
Short Long Term Debt Total	0.62	0.77		0.44	0.44	0.54	0.69	0.29	0.18	-0.16	0.16	-0.04	0.68	0.78	0.57	-0.66	-0.07	-0.27	0.01	-0.04	0.57	0.66	0.88	0.43	0.16	0.19
Other Current Liab	0.85	0.5	0.44		1.0	0.43	0.74	-0.29	-0.43	-0.13	0.18	-0.56	0.81	0.49	-0.09	-0.15	-0.42	-0.32	0.57	0.67	-0.15	0.33	0.31	-0.08	0.19	0.88
Total Current Liabilities	0.85	0.49	0.44	1.0		0.43	0.74	-0.29	-0.43	-0.13	0.17	-0.57	0.81	0.49	-0.09	-0.14	-0.42	-0.32	0.57	0.67	-0.15	0.33	0.3	-0.08	0.19	0.88
Total Stockholder Equity	0.75	0.82	0.54	0.43	0.43		0.33	0.26	0.19	-0.42	0.6	-0.58	0.81	0.79	0.17	-0.58	0.14	-0.6	0.58	0.2	-0.19	0.37	0.67	0.34	0.61	0.35
Net Debt	0.69	0.4	0.69	0.74	0.74	0.33		-0.31	-0.54	-0.33	-0.2	-0.43	0.66	0.4	0.33	-0.07	-0.61	-0.44	0.14	0.2	0.3	0.25	0.41	-0.17	-0.19	0.69
Retained Earnings	-0.12	0.51	0.29	-0.29	-0.29	0.26	-0.31		0.84	0.19	0.58	0.3	0.11	0.53	0.04	-0.66	0.62	0.17	0.14	-0.08	0.31	0.5	0.57	0.83	0.56	-0.54
Cash	-0.25	0.35	0.18	-0.43	-0.43	0.19	-0.54	0.84		0.15	0.55	0.34	-0.02	0.36	0.18	-0.61	0.7	0.16	-0.07	-0.27	0.19	0.42	0.47	0.78	0.52	-0.61
Other Assets	-0.22	-0.13	-0.16	-0.13	-0.13	-0.42	-0.33	0.19	0.15		-0.09	0.59	-0.35	-0.09	-0.37	0.0	0.45	0.96	-0.04	0.25	0.12	0.24	-0.28	0.11	-0.09	-0.33
Cash And Short Term Investments	0.39	0.7	0.16	0.18	0.17	0.6	-0.2	0.58	0.55	-0.09		-0.13	0.53	0.7	-0.09	-0.72	0.37	-0.2	0.52	0.28	-0.4	0.46	0.53	0.65	1.0	-0.09
Non Current Liabilities Total	-0.5	-0.2	-0.04	-0.56	-0.57	-0.58	-0.43	0.3	0.34	0.59	-0.13		-0.59	-0.15	0.05	-0.22	0.31	0.72	-0.56	-0.27	0.43	0.18	-0.05	0.3	-0.14	-0.81
Other Stockholder Equity	0.92	0.85	0.68	0.81	0.81	0.81	0.66	0.11	-0.02	-0.35	0.53	-0.59		0.83	0.14	-0.55	-0.16	-0.55	0.61	0.44	-0.12	0.5	0.72	0.28	0.53	0.62
Total Liab	0.75	1.0	0.78	0.49	0.49	0.79	0.4	0.53	0.36	-0.09	0.7	-0.15	0.83		0.24	-0.87	0.15	-0.26	0.44	0.27	0.13	0.76	0.89	0.64	0.7	0.15
Total Current Assets	0.08	0.24	0.57	-0.09	-0.09	0.17	0.33	0.04	0.18	-0.37	-0.09	0.05	0.14	0.24		-0.23	-0.32	-0.31	-0.66	-0.77	0.53	0.17	0.43	-0.01	-0.1	-0.1
Short Term Debt	-0.47	-0.85	-0.66	-0.15	-0.14	-0.58	-0.07	-0.66	-0.61	0.0	-0.72	-0.22	-0.55	-0.87	-0.23		-0.4	0.1	-0.23	-0.11	-0.18	-0.73	-0.87	-0.82	-0.71	0.25
Other Liab	-0.23	0.15	-0.07	-0.42	-0.42	0.14	-0.61	0.62	0.7	0.45	0.37	0.31	-0.16	0.15	-0.32	-0.4		0.39	0.23	0.09	-0.08	0.22	0.16	0.6	0.36	-0.52
Accounts Payable	-0.42	-0.3	-0.27	-0.32	-0.32	-0.6	-0.44	0.17	0.16	0.96	-0.2	0.72	-0.55	-0.26	-0.31	0.1	0.39		-0.23	0.08	0.2	0.09	-0.39	0.04	-0.2	-0.49
Non Current Assets Total	0.58	0.47	0.01	0.57	0.57	0.58	0.14	0.14	-0.07	-0.04	0.52	-0.56	0.61	0.44	-0.66	-0.23	0.23	-0.23		0.85	-0.53	0.2	0.2	0.24	0.53	0.5
Non Currrent Assets Other	0.51	0.27	-0.04	0.67	0.67	0.2	0.2	-0.08	-0.27	0.25	0.28	-0.27	0.44	0.27	-0.77	-0.11	0.09	0.08	0.85		-0.43	0.25	0.01	0.13	0.3	0.52
Long Term Debt	-0.16	0.1	0.57	-0.15	-0.15	-0.19	0.3	0.31	0.19	0.12	-0.4	0.43	-0.12	0.13	0.53	-0.18	-0.08	0.2	-0.53	-0.43		0.29	0.35	0.2	-0.42	-0.26
Net Receivables	0.42	0.73	0.66	0.33	0.33	0.37	0.25	0.5	0.42	0.24	0.46	0.18	0.5	0.76	0.17	-0.73	0.22	0.09	0.2	0.25	0.29		0.69	0.76	0.46	-0.02
Good Will	0.56	0.89	0.88	0.31	0.3	0.67	0.41	0.57	0.47	-0.28	0.53	-0.05	0.72	0.89	0.43	-0.87	0.16	-0.39	0.2	0.01	0.35	0.69		0.71	0.52	0.01
Common Stock Total Equity	0.09	0.62	0.43	-0.08	-0.08	0.34	-0.17	0.83	0.78	0.11	0.65	0.3	0.28	0.64	-0.01	-0.82	0.6	0.04	0.24	0.13	0.2	0.76	0.71		0.63	-0.4
Short Term Investments	0.41	0.7	0.16	0.19	0.19	0.61	-0.19	0.56	0.52	-0.09	1.0	-0.14	0.53	0.7	-0.1	-0.71	0.36	-0.2	0.53	0.3	-0.42	0.46	0.52	0.63		-0.08
Inventory	0.66	0.17	0.19	0.88	0.88	0.35	0.69	-0.54	-0.61	-0.33	-0.09	-0.81	0.62	0.15	-0.1	0.25	-0.52	-0.49	0.5	0.52	-0.26	-0.02	0.01	-0.4	-0.08

Click cells to compare fundamentals

MetLife Account Relationship Matchups

MetLife fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	944.4M	913.2M	869.4M	808.9M	762.3M	954.7M
Total Assets	740.5B	795.1B	759.7B	666.6B	687.6B	656.2B
Short Long Term Debt Total	16.9B	18.1B	17.4B	18.0B	18.8B	18.1B
Other Current Liab	(235M)	(393M)	(341M)	(2.8B)	190M	180.5M
Total Current Liabilities	235M	393M	341M	217M	309M	293.6M
Total Stockholder Equity	66.1B	74.6B	67.5B	27.0B	30.0B	46.4B
Net Debt	253M	(1.6B)	(2.6B)	(2.2B)	(1.8B)	(1.7B)
Retained Earnings	33.1B	36.5B	41.2B	42.0B	40.1B	24.7B
Cash	16.6B	19.8B	20.0B	20.2B	20.6B	12.6B
Other Assets	8.6B	6.1B	(10.1B)	357.5B	373.7B	392.4B
Cash And Short Term Investments	348.3B	378.5B	367.5B	301.9B	308.1B	188.5B
Liabilities And Stockholders Equity	740.5B	795.1B	759.7B	666.6B	687.6B	656.2B
Non Current Liabilities Total	25.7B	28.8B	26.8B	639.1B	657.0B	689.9B
Other Stockholder Equity	20.0B	20.0B	15.4B	12.2B	9.1B	8.6B
Total Liab	674.1B	720.3B	692.0B	639.3B	657.3B	609.5B
Total Current Assets	368.7B	396.4B	384.8B	297.0B	302.1B	286.7B
Accumulated Other Comprehensive Income	13.1B	18.1B	10.9B	(27.1B)	(19.2B)	(18.3B)
Short Term Debt	268M	235M	393M	341M	119M	113.1M
Other Liab	548.5B	663.5B	633.0B	512.5B	589.3B	618.8B
Accounts Payable	363M	129M	2.2B	20.8B	18.7B	19.7B
Non Current Assets Total	363.1B	392.7B	385.0B	12.1B	11.8B	11.3B
Non Currrent Assets Other	(363.1B)	(392.7B)	(385.0B)	(309.3B)	(164.7B)	(173.0B)
Long Term Debt	4.1B	4.0B	17.1B	17.8B	18.7B	13.0B
Net Receivables	20.4B	17.9B	17.3B	17.5B	29.2B	18.7B
Good Will	9.3B	10.1B	9.5B	9.3B	9.2B	7.7B
Short Term Investments	331.7B	358.7B	347.5B	281.7B	287.5B	190.6B
Inventory	(62.4B)	(59.9B)	(55.4B)	(104.3B)	(93.9B)	(89.2B)
Treasury Stock	(12.7B)	(13.8B)	(18.2B)	(21.5B)	(19.3B)	(18.3B)
Intangible Assets	19.1B	18.7B	18.3B	25.5B	20.9B	12.2B
Property Plant Equipment	2.8B	2.6B	2.2B	1.9B	2.1B	1.5B
Property Plant And Equipment Net	354.0B	381.7B	375.3B	1.9B	(148.6B)	(141.2B)
Other Current Assets	62.4B	59.9B	55.4B	(22.4B)	69.1B	97.5B
Noncontrolling Interest In Consolidated Entity	238M	259M	267M	247M	284.1M	303.9M
Retained Earnings Total Equity	33.1B	36.5B	41.2B	42.0B	48.2B	30.2B
Deferred Long Term Liab	9.1B	11.0B	9.7B	325M	373.8M	355.1M
Net Tangible Assets	56.8B	64.4B	57.9B	17.7B	16.0B	15.2B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MetLife Stock Analysis

When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC